Company

Ryan Beal, MD

Ryan Beal, M.D. is a serial entrepreneur focused on biopharma drug delivery innovation. He is recognized for his ability to leverage his scientific, R&D, and clinical acumen with a creative strategic and commercial mind. He has been involved with the launch of medical products with collective annual peak sales over $50 billion and been involved with the founding of multiple healthcare companies. Prior to his entrepreneurial endeavors, Ryan spent 7 years with McKinsey & Company where he was a leader in their Pharmaceutical Practice. He earned an M.D. with honors from the University of Pennsylvania School of Medicine and a BA with honors in Biophysical Chemistry from Dartmouth College.

Jim McGee

Jim McGee has over 20 years of corporate executive experience with Fortune 50 companies including Walt Disney Company, WellPoint, and Anthem. Jim’s start-up experience includes building one of Los Angeles’ first-ecommerce development firms, Guidance Solutions. The company was one of LA’s 15 fastest growing technology companies three years in a row, raised $25 million in growth capital, and continues to operate today. Prior to joining Dyve in 2018, Jim served as a regional CEO for American Red Cross for 7 years. He received his MBA from University of Southern California and BA in Economics from Wheaton College.

Lisa Misell, PhD

Lisa Misell, PhD has over 25 years of clinical research experience and 16 years of industry experience. She has managed clinical studies across all stages of development and in several therapeutic areas including oncology, neurology, aesthetics, dermatology and rheumatology. Prior to joining Dyve in 2016, Lisa served as Vice President of Clinical and Medical Affairs at Ulthera (acquired by Merz), Senior Director of Clinical Operations at Suneva Medical, Therapeutic Area Manager at Allergan, Senior Consultant at Campbell Alliance, and Director of Oncology at KineMed, Inc. Lisa received her PhD in Molecular and Metabolic Biochemistry from University of California, Berkeley.

Nathan Fitzsimmons, PhD

Nathan Fitzsimmons, PhD joined Dyve in 2015 after spending over 5 years with McKinsey & Company consulting companies in the biotech, pharma, and medical device industries. Nathan received his PhD in Neurobiology from Duke University and he also received his BSE in Biomedical Engineering from Duke University.

Scott P. Barlow, Esq.

Scott P. Barlow joined Dyve in 2018 with over 23 years of experience as an attorney and over 19 years of experience serving as a general counsel and secretary to the Board of Directors for public and private companies. As the Executive Vice President and General Counsel for Conversant, Inc. (a publicly traded advertising, technology company), Scott spent 15 years overseeing the Company’s worldwide legal department. Scott has substantial experience in licensing, IP prosecution, SEC compliance and led the legal team that negotiated over 17 mergers and acquisitions during his tenure with Conversant. Scott left Conversant in 2015 after it was acquired by Alliance Data Systems for $2.3 billion. Prior to Conversant, Scott was the Vice President & General Counsel with Mediaplex, Inc. and helped lead Mediaplex’s IPO process in 1999. In 2011, Scott was named one of the top-25 general counsel in the State of California by the Los Angeles Daily Journal. He holds a Bachelor of Science in Advertising from the University of Florida and a Juris Doctor from the University of Akron School of Law.